{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:19:01Z","timestamp":1773155941197,"version":"3.50.1"},"reference-count":58,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2012.0180","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:20:04Z","timestamp":1525238404000},"source":"Crossref","is-referenced-by-count":17,"title":["The Diagnosis and Treatment of Minimal Hepatic Encephalopathy"],"prefix":"10.3238","author":[{"given":"Tianzuo","family":"Zhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Stremmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2012,3,9]]},"reference":[{"key":"10.3238\/arztebl.2012.0180_ref1","doi-asserted-by":"crossref","unstructured":"Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT: Hepatic encephalopathy\u2014definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716\u201321","DOI":"10.1053\/jhep.2002.31250"},{"key":"10.3238\/arztebl.2012.0180_ref2","doi-asserted-by":"crossref","unstructured":"Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H: Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768\u201373","DOI":"10.1016\/S0168-8278(01)00026-5"},{"key":"10.3238\/arztebl.2012.0180_ref3","doi-asserted-by":"crossref","unstructured":"Schomerus H, Hamster W: Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 37\u201341","DOI":"10.1023\/A:1011610427843"},{"key":"10.3238\/arztebl.2012.0180_ref4","doi-asserted-by":"crossref","unstructured":"Groeneweg M, Quero JC, De Bruijn I, et al.: Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45\u20139","DOI":"10.1002\/hep.510280108"},{"key":"10.3238\/arztebl.2012.0180_ref5","doi-asserted-by":"crossref","unstructured":"Roman E, Cordoba J, Torrens M, et al.: Minimal hepatic encephalopathy is associated with falls. Am J Gastroenterol 2011; 106: 476\u201382","DOI":"10.1038\/ajg.2010.413"},{"key":"10.3238\/arztebl.2012.0180_ref6","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Saeian K, Schubert CM, et al.: Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 2009; 50: 1175\u201383","DOI":"10.1002\/hep.23128"},{"key":"10.3238\/arztebl.2012.0180_ref7","doi-asserted-by":"crossref","unstructured":"Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J: Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718\u201323","DOI":"10.1111\/j.1572-0241.2001.04130.x"},{"key":"10.3238\/arztebl.2012.0180_ref8","doi-asserted-by":"crossref","unstructured":"Amodio P, Del Piccolo F, Marchetti P, et al.: Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999; 29: 1662\u20137","DOI":"10.1002\/hep.510290619"},{"key":"10.3238\/arztebl.2012.0180_ref9","doi-asserted-by":"crossref","unstructured":"Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R: Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007; 45: 549\u201359","DOI":"10.1002\/hep.21533"},{"key":"10.3238\/arztebl.2012.0180_ref10","doi-asserted-by":"crossref","unstructured":"Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK: Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011; 106: 307\u201316","DOI":"10.1038\/ajg.2010.455"},{"key":"10.3238\/arztebl.2012.0180_ref11","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Heuman DM, Wade JB, et al.: Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011; 140: 478\u201387","DOI":"10.1053\/j.gastro.2010.08.061"},{"key":"10.3238\/arztebl.2012.0180_ref12","doi-asserted-by":"crossref","unstructured":"Lockwood AH, Yap EW, Wong WH: Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991; 11: 337\u201341","DOI":"10.1038\/jcbfm.1991.67"},{"key":"10.3238\/arztebl.2012.0180_ref13","doi-asserted-by":"crossref","unstructured":"Shawcross DL, Wright G, Olde Damink SW, Jalan R: Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125\u201338","DOI":"10.1007\/s11011-006-9042-1"},{"key":"10.3238\/arztebl.2012.0180_ref14","doi-asserted-by":"crossref","unstructured":"Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM: Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441\u20139","DOI":"10.1002\/hep.20194"},{"key":"10.3238\/arztebl.2012.0180_ref15","doi-asserted-by":"crossref","unstructured":"Ong JP, Aggarwal A, Krieger D, et al.: Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003; 114: 188\u201393","DOI":"10.1016\/S0002-9343(02)01477-8"},{"key":"10.3238\/arztebl.2012.0180_ref16","doi-asserted-by":"crossref","unstructured":"Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D: Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357\u201366","DOI":"10.1053\/jhep.2002.30957"},{"key":"10.3238\/arztebl.2012.0180_ref17","doi-asserted-by":"crossref","unstructured":"Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W: Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 2002; 17: 29\u201340","DOI":"10.1023\/A:1014000313824"},{"key":"10.3238\/arztebl.2012.0180_ref18","doi-asserted-by":"crossref","unstructured":"Blei AT, Cordoba J: Hepatic Encephalopathy. Am J Gastroenterol 2001; 96: 1968\u201376","DOI":"10.1111\/j.1572-0241.2001.03964.x"},{"key":"10.3238\/arztebl.2012.0180_ref19","doi-asserted-by":"crossref","unstructured":"Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB: Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000; 45: 1549\u201352","DOI":"10.1023\/A:1005556826152"},{"key":"10.3238\/arztebl.2012.0180_ref20","doi-asserted-by":"crossref","unstructured":"Watanabe A, Sakai T, Sato S, et al.: Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997; 26: 1410\u20134","DOI":"10.1002\/hep.510260606"},{"key":"10.3238\/arztebl.2012.0180_ref21","doi-asserted-by":"crossref","unstructured":"Sharma BC, Sharma P, Agrawal A, Sarin SK: Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009; 137: 885\u201391","DOI":"10.1053\/j.gastro.2009.05.056"},{"key":"10.3238\/arztebl.2012.0180_ref22","doi-asserted-by":"crossref","unstructured":"Bass NM, Mullen KD, Sanyal A, et al.: Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 1071\u201381","DOI":"10.1056\/NEJMoa0907893"},{"key":"10.3238\/arztebl.2012.0180_ref23","doi-asserted-by":"crossref","unstructured":"Plauth M, Cabre E, Riggio O, et al.: ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006; 25: 285\u201394","DOI":"10.1016\/j.clnu.2006.01.018"},{"key":"10.3238\/arztebl.2012.0180_ref24","doi-asserted-by":"crossref","unstructured":"Malaguarnera M, Gargante MP, Cristaldi E, et al.: Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 2008; 53: 3018\u201325","DOI":"10.1007\/s10620-008-0238-6"},{"key":"10.3238\/arztebl.2012.0180_ref25","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Saeian K, Christensen KM, et al.: Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008; 103: 1707\u201315.","DOI":"10.1111\/j.1572-0241.2008.01861.x"},{"key":"10.3238\/arztebl.2012.0180_ref26","doi-asserted-by":"crossref","unstructured":"Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, et al.: Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol 2010; 25: 1029\u201341","DOI":"10.1111\/j.1440-1746.2010.06318.x"},{"key":"10.3238\/arztebl.2012.0180_ref27","doi-asserted-by":"crossref","unstructured":"Sharma P, Sharma BC, Puri V, Sarin SK: Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2008; 103: 1406\u201312","DOI":"10.1111\/j.1572-0241.2008.01830.x"},{"key":"10.3238\/arztebl.2012.0180_ref28","doi-asserted-by":"crossref","unstructured":"Sarin SK, Nundy S: Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver 1985; 5: 142\u20136","DOI":"10.1111\/j.1600-0676.1985.tb00229.x"},{"key":"10.3238\/arztebl.2012.0180_ref29","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Etemadian A, Hafeezullah M, Saeian K: Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology 2007; 45: 833\u20134","DOI":"10.1002\/hep.21515"},{"key":"10.3238\/arztebl.2012.0180_ref30","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K: Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102: 1903\u20139","DOI":"10.1111\/j.1572-0241.2007.01424.x"},{"key":"10.3238\/arztebl.2012.0180_ref31","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, et al.: Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008; 47: 596\u2013604","DOI":"10.1002\/hep.22032"},{"key":"10.3238\/arztebl.2012.0180_ref32","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Hafeezullah M, Zadvornova Y, Martin E, Schubert CM, Gibson DP, et al.: The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol 2009; 104: 898\u2013905","DOI":"10.1038\/ajg.2009.7"},{"key":"10.3238\/arztebl.2012.0180_ref33","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Saeian K, Hafeezullah M, Hoffmann RG, Hammeke TA: Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin Gastroenterol Hepatol 2008; 6: 1135\u20139; quiz 1065","DOI":"10.1016\/j.cgh.2008.05.025"},{"key":"10.3238\/arztebl.2012.0180_ref34","doi-asserted-by":"crossref","unstructured":"Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR: Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531\u20135","DOI":"10.1046\/j.1440-1746.2001.02487.x"},{"key":"10.3238\/arztebl.2012.0180_ref35","doi-asserted-by":"crossref","unstructured":"Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, et al.: Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010; 55: 2381\u201390","DOI":"10.1007\/s10620-010-1249-7"},{"key":"10.3238\/arztebl.2012.0180_ref36","doi-asserted-by":"crossref","unstructured":"Cooper AJ, Plum F: Biochemistry and physiology of brain ammonia. Physiol Rev 1987; 67: 440\u2013519","DOI":"10.1152\/physrev.1987.67.2.440"},{"key":"10.3238\/arztebl.2012.0180_ref37","doi-asserted-by":"crossref","unstructured":"Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, et al.: The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598\u2013604","DOI":"10.1016\/S0168-8278(01)00181-7"},{"key":"10.3238\/arztebl.2012.0180_ref38","doi-asserted-by":"crossref","unstructured":"Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A, et al.: Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640\u20134","DOI":"10.1016\/S0016-5085(99)70457-9"},{"key":"10.3238\/arztebl.2012.0180_ref39","doi-asserted-by":"crossref","unstructured":"Ahboucha S, Butterworth RF: The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Int 2008; 52: 575\u201387","DOI":"10.1016\/j.neuint.2007.05.004"},{"key":"10.3238\/arztebl.2012.0180_ref40","doi-asserted-by":"crossref","unstructured":"Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB: In vivo imaging of cerebral \u201eperipheral benzodiazepine binding sites\u201c in patients with hepatic encephalopathy. Gut 2006; 55: 547\u201353","DOI":"10.1136\/gut.2005.075051"},{"key":"10.3238\/arztebl.2012.0180_ref41","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201eMini-mental state\u201c. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189\u201398","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"10.3238\/arztebl.2012.0180_ref42","doi-asserted-by":"crossref","unstructured":"Romero-Gomez M, Cordoba J, Jover R, del Olmo JA, Ramirez M, Rey R, et al.: Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007; 45: 879\u201385","DOI":"10.1002\/hep.21586"},{"key":"10.3238\/arztebl.2012.0180_ref43","doi-asserted-by":"crossref","unstructured":"Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, et al.: Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 1999; 110: 1334\u201344","DOI":"10.1016\/S1388-2457(99)00076-0"},{"key":"10.3238\/arztebl.2012.0180_ref44","doi-asserted-by":"crossref","unstructured":"Saxena N, Bhatia M, Joshi YK, Garg PK, Tandon RK: Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J Gastroenterol Hepatol 2001; 16: 322\u20137","DOI":"10.1046\/j.1440-1746.2001.02388.x"},{"key":"10.3238\/arztebl.2012.0180_ref45","doi-asserted-by":"crossref","unstructured":"Weissenborn K, Ehrenheim C, Hori A, Kubicka S, Manns MP: Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab Brain Dis 1995; 10: 219\u201331","DOI":"10.1007\/BF02081027"},{"key":"10.3238\/arztebl.2012.0180_ref46","doi-asserted-by":"crossref","unstructured":"Naegele T, Grodd W, Viebahn R, Seeger U, Klose U, Seitz D, et al.: MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000; 216: 683\u201391","DOI":"10.1148\/radiology.216.3.r00se27683"},{"key":"10.3238\/arztebl.2012.0180_ref47","doi-asserted-by":"crossref","unstructured":"Kale RA, Gupta RK, Saraswat VA, Hasan KM, Trivedi R, Mishra AM, et al.: Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43: 698\u2013706","DOI":"10.1002\/hep.21114"},{"key":"10.3238\/arztebl.2012.0180_ref48","doi-asserted-by":"crossref","unstructured":"Trzepacz PT, Tarter RE, Shah A, Tringali R, Faett DG, Van Thiel DH: SPECT scan and cognitive findings in subclinical hepatic encephalopathy. J Neuropsychiatry Clin Neurosci 1994; 6: 170\u20135","DOI":"10.1176\/jnp.6.2.170"},{"key":"10.3238\/arztebl.2012.0180_ref49","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Sanyal AJ, Bell D, Gilles H, Heuman DM: Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther 2010; 31: 1012\u20137","DOI":"10.1111\/j.1365-2036.2010.04257.x"},{"key":"10.3238\/arztebl.2012.0180_ref50","doi-asserted-by":"crossref","unstructured":"van Leeuwen PA, van Berlo CL, Soeters PB : New mode of action for lactulose. Lancet 1988; 1: 55\u20136","DOI":"10.1016\/S0140-6736(88)91033-1"},{"key":"10.3238\/arztebl.2012.0180_ref51","doi-asserted-by":"crossref","unstructured":"Als-Nielsen B, Gluud LL, Gluud C: Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 2004; 328: 1046","DOI":"10.1136\/bmj.38048.506134.EE"},{"key":"10.3238\/arztebl.2012.0180_ref52","doi-asserted-by":"crossref","unstructured":"Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al.: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573\u201383","DOI":"10.1016\/S0016-5085(77)80135-2"},{"key":"10.3238\/arztebl.2012.0180_ref53","doi-asserted-by":"crossref","unstructured":"Les I, Doval E, Garcia-Martinez R, Planas M, Cardenas G, Gomez P, et al.: Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol 2011; 106: 1081\u20138","DOI":"10.1038\/ajg.2011.9"},{"key":"10.3238\/arztebl.2012.0180_ref54","doi-asserted-by":"crossref","unstructured":"Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Gortelmeyer R, et al.: Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol 1998; 28: 856\u201364","DOI":"10.1016\/S0168-8278(98)80237-7"},{"key":"10.3238\/arztebl.2012.0180_ref55","doi-asserted-by":"crossref","unstructured":"Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, et al.: Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 2008; 53: 3018\u201325","DOI":"10.1007\/s10620-008-0238-6"},{"key":"10.3238\/arztebl.2012.0180_ref56","doi-asserted-by":"crossref","unstructured":"Tuerk MJ, Fazel N: Zinc deficiency. Curr Opin Gastroenterol 2009; 25: 136\u201343","DOI":"10.1097\/MOG.0b013e328321b395"},{"key":"10.3238\/arztebl.2012.0180_ref57","unstructured":"Conn HO, Bircher J: Quantifying the severity of hepatic encephalopathy: syndromes and therapies. In: Conn HO, Bircher J (eds.) Hepatic encephalopathy: syndromes and therapies. East Lansing MI: Medi Ed Press. 1993: 13\u201326."},{"key":"10.3238\/arztebl.2012.0180_ref58","unstructured":"Spezialambulanz f\u00fcr Ged\u00e4chtnisst\u00f6rungen am AKH Wien. (Internet). Vienna: Department of Neurology, Medical Faculty of Vienna, (cited 2011 Aug 22). www.meduniwien.ac.at\/Neurologie\/gedamb\/diag\/diag08.htm"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2012.0180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T04:32:57Z","timestamp":1638851577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2012.0180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,9]]},"references-count":58,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2012.0180","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/s11011-016-9878-y","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,9]]}}}